吉药控股(300108.SZ):2019年年报及2020年第一季度报告披露时间调整为4月29日
格隆汇4月21日丨吉药控股(300108.SZ)公布,公司原定于2020年4月25日披露《2019年年度报告》,原定于2020年4月27日披露《2020年第一季度报告》,因受新型冠状病毒肺炎疫情的影响,全国各地复工都有所延迟,公司部分下属公司处在疫情较为严重的地区,导致审计机构入场时间及各项审计程序完成时间比原计划大幅推后。根据审计机构目前的审计进度,预计无法按照原计划时间披露。
公司为确保《2019年年度报告》与《2020年第一季度报告》的准确性和完整性,本着审慎原则及对广大投资者负责的态度,经公司与年报审计会计师事务所慎重研究并经深圳证券交易所同意,决定将《2019年年度报告》的披露时间由2020年4月25日调整为2020年4月29日,将《2020年第一季度报告》的披露时间由2020年4月27日调整为2020年4月29日。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.